Form D · Biotechnology
Calidi Biotherapeutics, Inc.
San Diego, CA · CIK 0001758478
Offering snapshot reported Jun 29, 2023 · SEC filing
- Reported sold
- $5M Offering amount: $25M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 20, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 29, 2023 | Initial | $4,999,975 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired, Other
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $50K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-485625
Series B Preferred Stock and Common Stock issuable conversion of Series B Preferred Stock
Series B Preferred Stock and Common Stock
Reflects 1% of sold amount, commission ranges from 1%-5%
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Arcadia Securities, LLC | 44656 | Brookline Capital Markets |
Source: Form D, filed Jun 29, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Allan Camaisa | Director, Executive |
| Tony Kalajian | Executive |
| Heehyoung Lee | Director |
| Scott Leftwich | Director |
| Boris Minev | Executive |
| George Ng | Director |
| Amish Patel | Executive |
| Wendy Pizarro | Executive |
| David Sans | Executive |
| Anthony F. Santidrian | Executive |
| James Schoeneck | Director |
| Stephen Thesing | Executive |
| Alfonso Zulueta | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4475 Executive Drive, Suite 200
San Diego, CA, 92121
San Diego, CA, 92121